NCT04318015View on ClinicalTrials.gov

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)

PHASE3CompletedINTERVENTIONAL

Enrollment

289

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

March 31, 2021

Conditions

COVID-19Severe Acute Respiratory Syndrome

Interventions

DRUG

Hydroxychloroquine

All treatment will be administered orally.

DRUG

Placebo oral tablet

All placebo will be administered orally

Trial Locations (1)

14080

"Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas", Mexico City

All Listed Sponsors

lead

National Institute of Respiratory Diseases, Mexico

OTHER_GOV

NCT04318015 - Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) | Biotech Hunter | Biotech Hunter